GRDN — Guardian Pharmacy Services, Inc.
—
NYSE ·
Consumer Staples ·
Drug Retail ·
CIK 1802255 ·
Last close
$50.33
Market Cap
$3.19B
52W High
$50.80
52W Low
$26.34
ADV30
481,420
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 371,070,000 | 85,223,000 | 25,063,000 | 18,680,000 | 491,776,000 | 119,655,000 | 212,056,000 |
| Jun 2026 | 351,768,000 | 80,044,000 | 20,644,000 | 21,872,000 | 443,578,000 | 89,807,000 | 185,936,000 |
| Mar 2026 | 336,595,000 | 76,309,000 | 17,675,000 | 13,295,000 | 426,941,000 | 64,893,000 | 194,517,000 |
| Dec 2025 | 397,616,000 | 85,502,000 | 30,762,000 | 20,923,000 | 412,658,000 | 65,619,000 | 194,734,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$98,856,000
Investing CF
$-22,732,000
Financing CF
$-5,134,000
CapEx
$-19,071,000
Dividends Paid
$0
Buybacks
$-30,276,000
EPS Diluted TTM
$1.03
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$101,510,000
Inventory
$50,442,000
Receivables
$103,769,000
ST Investments
—
EBIT TTM
$96,446,000
Pretax Income TTM
$95,815,000
Interest Exp TTM
$631,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,457,048,960
EBITDA
$117,759,000
Free Cash Flow
$75,564,752
Enterprise Value
$2,619,001,600
Total Cash
$119,655,000
Total Debt
$40,599,000
Shares Out
63,320,300
Trailing EPS
$1.17
Book Value
$4.22
ROE
32.0%
ROA
13.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,448,685,000 | 72,701,000 | 49,219,000 | 412,658,000 | 194,734,000 | 205,759,000 | 100,255,000 |
| Dec 2024 | 1,228,409,000 | -62,920,000 | -87,287,000 | 320,810,000 | 170,834,000 | 142,671,000 | 57,960,000 |
| Dec 2023 | 1,046,193,000 | 40,946,000 | 23,902,000 | 271,165,000 | 211,306,000 | 0 | 70,819,000 |
| Dec 2022 | 908,909,000 | 51,990,000 | 35,421,000 | 256,114,000 | 180,185,000 | 0 | 48,522,000 |
TTM Snapshot
Revenues TTM
$1,463,406,000
NetIncome TTM
$65,908,000
OpCashFlow TTM
—
Assets (Latest)
$443,578,000
Forward EPS
$1.43
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $48.84 · call volume: 20 · put volume: 19
Expected Move to 2027-01-15:
±$16.15
(33.07%) —
implied range
$32.69 –
$64.99
· ATM straddle on $50.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CVS | CVS HEALTH Corp | $109.79B | $85.81 | — |
| PETS | PETMED EXPRESS INC | $20.00M | $0.90 | — |
| YI | 111, Inc. | $14.39M | $2.77 | — |
| RDGT | Ridgetech Inc. | $3.74M | $1.03 | — |
| CANN | TREES Corp (Colorado) | — | $nan | — |
News headlines (Yahoo Finance, 1h cache)
Guardian Pharmacy Services, Inc. (GRDN) Hits Fresh High: Is There Still Room to Run?
2026-11-18 13:15 · Yahoo
Guardian Pharmacy Services, Inc. to Participate in Upcoming Citi Annual Global Healthcare Conference
2026-11-16 21:30 · Yahoo
NBIX or GRDN: Which Is the Better Value Stock Right Now?
2026-11-10 19:38 · Yahoo
Is Guardian Pharmacy Services (GRDN) Stock Reasonable After Raised Guidance?
2026-11-09 21:08 · Yahoo
Guardian Pharmacy Services (GRDN) Jumped, But What Is Behind The Move?
2026-11-09 19:15 · Yahoo
Guardian Pharmacy Services Stock Gets A Guidance Lift After Profit Jump
2026-11-09 18:10 · Yahoo
NBIX vs. GRDN: Which Stock Is the Better Value Option?
2026-11-09 15:40 · Yahoo
Guardian Pharmacy Services Inc (GRDN) (Q3 2026) Earnings Call Highlights: Raised Guidance and ...
2026-11-07 15:10 · Yahoo
What Guardian Pharmacy Services (GRDN) Said on Its Q3 Earnings Call
2026-11-07 13:19 · Yahoo
Guardian Pharma (GRDN) Q3 2026 Earnings Call Transcript
2026-11-06 17:34 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.